Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q1 FY25 results · Apr–Jun 2024
Unichem Laboratories reported revenue from operations of ₹446.43 crore (up 5.5% from Q1 FY24) and net profit of ₹9.26 crore for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 446.43 | 423.19 | +5.5% | 431.70 | +3.4% |
| Other income | 3.86 | 8.63 | −55.3% | 6.15 | −37.3% |
| Total income | 450.29 | 431.82 | +4.3% | 437.85 | +2.8% |
| Profit before tax | 15.00 | 2.12 | +608.7% | (125.87) | Turned profit |
| Net profit for the period | 9.26 | (0.67) | Turned profit | (129.31) | Turned profit |
| EPS, basic (₹) | 1.31 | (0.09) | Turned profit | (18.37) | Turned profit |
| Net margin (%) | 2.1 | -0.2 | -30.0 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 389.75 | 346.67 | +12.4% | 399.24 | −2.4% |
| Other income | 8.77 | 5.83 | +50.6% | 7.04 | +24.7% |
| Total income | 398.52 | 352.49 | +13.1% | 406.28 | −1.9% |
| Profit before tax | 21.48 | (15.70) | Turned profit | (114.97) | Turned profit |
| Net profit for the period | 21.48 | (15.70) | Turned profit | (114.97) | Turned profit |
| EPS, basic (₹) | 3.05 | (2.23) | Turned profit | (16.33) | Turned profit |
| Net margin (%) | 5.5 | -4.5 | -28.8 |
Consolidated
- Filed with BSE
- 20 Aug 2024, 10:00 IST
- Board meeting
- 08 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 20 Aug 2024, 10:00 IST
- Board meeting
- 08 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE